COMP and cancer: Pan-cancer analysis revealed that COMP was highly expressed in various cancers, such as BLCA, BRCA, CESC, CHOL, COAD, ECSC, HNSC, LIHC, LUAD, LUSC, PAAD, READ, SKCM, STAD, THCA, and UCEC (Figure 5A).